Innate Pharma SA Increase Decrease In Working Capital
Innate Pharma SA (IPHA) reported Increase Decrease In Working Capital of EUR 10.63 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-04-01.
Financial Statements › Notes
ifrs-full:IncreaseDecreaseInWorkingCapital · last filed 2026-04-01
| Period end | Increase Decrease In Working Capital 6 month | Increase Decrease In Working Capital 12 month | Increase Decrease In Working Capital 12 month as first filed |
|---|---|---|---|
| 2025-12-31 | 10.63M EUR 20-F · filed 2026-04-01 | ||
| 2025-06-30 | 14.18M EUR 6-K · filed 2025-09-17 | ||
| 2024-12-31 | -39.16M EUR 20-F · filed 2026-04-01 | ||
| 2024-06-30 | -26.60M EUR 6-K · filed 2025-09-17 | ||
| 2023-12-31 | 32.09M EUR 20-F · filed 2026-04-01 | 32.09M EUR 20-F · filed 2024-04-04 | |
| 2023-06-30 | 18.53M EUR 6-K · filed 2024-09-12 | ||
| 2022-12-31 | 12.50M EUR 20-F · filed 2025-04-30 | 12.50M EUR 20-F · filed 2023-04-06 | |
| 2022-06-30 | 10.98M EUR 6-K · filed 2023-09-14 | ||
| 2021-12-31 | 9.88M EUR 20-F · filed 2024-04-04 | 9.88M EUR 20-F · filed 2022-04-04 | |
| 2021-06-30 | 12.64M EUR 6-K · filed 2022-09-15 | ||
| 2020-12-31 | 49.21M EUR 20-F · filed 2023-04-06 | ||
| 2020-06-30 | 57.59M EUR 6-K · filed 2021-09-15 | ||
| 2019-12-31 | -40.25M EUR 20-F · filed 2022-04-04 | -40.24M EUR 20-F · filed 2020-04-24 | |
| 2018-12-31 | 47.10M EUR 20-F · filed 2021-04-27 | ||
| 2017-12-31 | 16.98M EUR 20-F · filed 2020-04-24 |